OMERS

OMERS and Oxford Properties Joins Lime Connect as a Corporate Partner

Retrieved on: 
Thursday, August 31, 2023
OMERS, Partnership, Disability, Network, Lime, Culture, Management

TORONTO and NEW YORK, Aug. 31, 2023 /PRNewswire-PRWeb/ -- Lime Connect (Lime) is pleased to announce that OMERS and Oxford Properties (OMERS) has joined the not-for-profit organization as a corporate partner in Canada to connect with high potential candidates who have disabilities

Key Points: 
  • The company will leverage The Lime Community platform and other connection points to identify university students and experienced professionals interested in exploring career opportunities with OMERS.
  • Andrew Masson, president of Lime Connect Canada's board of directors, says "Lime Connect is excited to welcome OMERS to our corporate partner group.
  • OMERS encourages candidates who have disabilities, and an interest in exploring a future with OMERS, apply to attend Lime Connect's numerous upcoming recruitment receptions across the provinces, and virtually.
  • Disabled university students and experienced professionals can learn more about Lime's career, community, and professional development resources; and apply to OMERS roles directly, by joining The Lime Network.

OMERS reports a good start to 2023

Retrieved on: 
Wednesday, August 16, 2023
OMERS, Plan, Bank

TORONTO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- OMERS generated a net investment return of 3.1%, or a gain of $3.8 billion, during the six-month period from January 1 to June 30, 2023.

Key Points: 
  • TORONTO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- OMERS generated a net investment return of 3.1%, or a gain of $3.8 billion, during the six-month period from January 1 to June 30, 2023.
  • Over the 12 months ended June 30, 2023, the Plan earned a net investment return of 7.8%, or a gain of $9.2 billion.
  • At June 30, 2023, net assets totaled $127.4 billion, an increase of $7.9 billion over the last 12 months.
  • “We have had a good start to the year, generating almost $4 billion in returns on behalf of our members,” said Blake Hutcheson, OMERS President and CEO.

Premise Health Appoints Chief Revenue Officer and Executive Vice President of Growth

Retrieved on: 
Tuesday, August 8, 2023
University, International Economic Development Council, American Heart Association, Marketing, Harvard University, Culture, EVP, Brock University, Health, Brochu, Organization, Miller, Harvard University endowment, Acquisition, Investment, Economic development, CRM, OMERS, Growth, Cincinnati, Commerce, Management

BRENTWOOD, Tenn., Aug. 8, 2023 /PRNewswire/ -- Premise Health, the largest direct health care provider and one of the largest digital providers in the country, announced the addition of two key executives to its already-tenured leadership team. Ben Miller joined the organization as the company's chief revenue officer (CRO), and Derek Brochu has been named executive vice president of growth and development.

Key Points: 
  • Ben Miller joined the organization as the company's chief revenue officer (CRO), and Derek Brochu has been named executive vice president of growth and development.
  • Premise Health announced the addition of a chief revenue officer and EVP of growth.
  • Miller joins Premise with more than 20 years of health care sales experience.
  • "Their combined extensive experience, familiarity with Premise, and deep understanding of our growth potential will help Premise maintain its position as a market leader.

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p.m. ET

Retrieved on: 
Monday, August 7, 2023
Other Health, Research, General Health, Pharmaceutical, Infectious Diseases, Clinical Trials, Science, COVID-19, Biotechnology, FDA, Other Science, Health, Asthma, Therapy, Heart, SARS-CoV-2, Clinical trial, Pharmacokinetics, Fast Track, Antibody, Sale, Medication, Chronic obstructive pulmonary disease, RSV, Patient, AbbVie, Glecaprevir/pibrentasvir, Viral, OMERS, Viral load, Upper respiratory tract infection, Capsid, Regulation of tobacco by the U.S. Food and Drug Administration, HCV, Food, Safety, SPRINT, Pharmaceutical industry, Life insurance

(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today reported financial results for its fiscal third quarter ended June 30, 2023.

Key Points: 
  • (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today reported financial results for its fiscal third quarter ended June 30, 2023.
  • “Our fiscal third quarter was marked by important progress in our pipeline, most notably across our RSV and COVID-19 programs.
  • In RSV, we were pleased to report positive Phase 1 results for EDP-323 in healthy volunteers, demonstrating favorable safety, tolerability, and pharmacokinetics.
  • The increase was primarily due to the timing of clinical trial expenses in the company’s virology programs.

Michael Hill appointed to lead OMERS Infrastructure

Retrieved on: 
Wednesday, August 2, 2023
Morgan Stanley, OMERS, Nomura Securities, Deutsche Bank, Financial services, Asset management, Infrastructure

TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- OMERS today announced that Michael Hill has been appointed Executive Vice President & Global Head of Infrastructure at OMERS.

Key Points: 
  • TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- OMERS today announced that Michael Hill has been appointed Executive Vice President & Global Head of Infrastructure at OMERS.
  • Michael, who joins OMERS on 5 September and will be based in New York, and report to Chief Investment Officer Ralph Berg.
  • At OMERS he will have accountability and oversight for our global infrastructure investment and asset management programs.
  • OMERS Infrastructure has more than 90 investment professionals around the world and has a portfolio of 30 assets in North America, Europe and Asia-Pacific.

OMERS Infrastructure Announces Strategic Investment in Beanfield Metroconnect

Retrieved on: 
Tuesday, July 18, 2023
Partnership, Davies Ward Phillips & Vineberg, Senior, TD, TD Securities, DigitalBridge, OMERS, Growth, McCarthy, Asset management, Cryptocurrency, Battle of the Beanfield

TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- OMERS Infrastructure has announced that OMERS has agreed to provide a significant capital commitment to Beanfield Technologies Inc. (‘Beanfield’).

Key Points: 
  • TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- OMERS Infrastructure has announced that OMERS has agreed to provide a significant capital commitment to Beanfield Technologies Inc. (‘Beanfield’).
  • DigitalBridge, an initial investor in Beanfield in 2019, will continue to hold the majority stake in the company and this investment marks an inaugural partnership between OMERS and DigitalBridge.
  • Peter Gray and Jenine Krause, both Managing Directors at OMERS Infrastructure, will be joining Beanfield’s Board of Directors.
  • This collaboration underscored our dedication to investing in infrastructure projects that will shape the future of connectivity in Canada.”
    Dan Armstrong, CEO, Beanfield Metroconnect, added: “We welcome OMERS to Beanfield, their investment is a validation of our strategy.

ABP and OMERS to acquire Dutch energy infrastructure solutions business Kenter

Retrieved on: 
Monday, July 3, 2023
Allen & Overy, Employment, Senior, ABP, Sale, Acquisition, Investment, Trustee, OMERS, APG, Renewable energy, Kenter, EU

Kenter is an energy infrastructure solutions business providing medium-voltage infrastructure – including transformers and switchgear – and meters to over 25,000 commercial and industrial business customers in the Netherlands and Belgium.

Key Points: 
  • Kenter is an energy infrastructure solutions business providing medium-voltage infrastructure – including transformers and switchgear – and meters to over 25,000 commercial and industrial business customers in the Netherlands and Belgium.
  • This investment is done by APG Asset Management on behalf of ABP, the largest pension fund in the Netherlands; OMERS Infrastructure is investing on behalf of OMERS, one of the largest pension plans in Canada.
  • ABP and OMERS investment in Kenter will be the consortium’s second joint investment in the Dutch B2B energy solutions sector, after reaching close on their investment in Groendus in November last year.
  • We look forward to growing a B2B energy solutions platform in the region, delivering energy infrastructure for businesses looking to meet their sustainability goals.”
    Erik van der Ende, CEO of Kenter, said: “I am delighted with the choice of ABP and OMERS Infrastructure.

Introhive Appoints Saeideh Fard as New Chief Financial Officer

Retrieved on: 
Tuesday, May 16, 2023
Hellman & Friedman, Travel, B2B, NB, Meltwater, Customer intelligence, Organization, Marketwired, Sysomos, CFO, OMERS, Growth, Salesforce, Bermuda, Financial management, Fard, Management, Software as a service

FREDERICTON, NB, May 16, 2023 /PRNewswire/ -- Introhive, the world's leading Customer Intelligence Platform, is thrilled to announce the appointment of Saeideh Fard as its new Chief Financial Officer.

Key Points: 
  • FREDERICTON, NB, May 16, 2023 /PRNewswire/ -- Introhive, the world's leading Customer Intelligence Platform, is thrilled to announce the appointment of Saeideh Fard as its new Chief Financial Officer.
  • Fard, a seasoned executive with extensive background in SaaS, finance, and operations, brings a wealth of scaling expertise to the Introhive team.
  • Introhive, the leading Customer Intelligence Platform, appoints Saeideh Fard as its new Chief Financial Officer.
  • Fard expressed her excitement about joining the Introhive team, stating, "I am thrilled to join Introhive, a company at the forefront of innovation in the Customer Intelligence space.

Introhive Appoints Saeideh Fard as New Chief Financial Officer

Retrieved on: 
Tuesday, May 16, 2023
Hellman & Friedman, Travel, B2B, NB, Meltwater, Customer intelligence, Organization, Marketwired, Sysomos, CFO, OMERS, Growth, Salesforce, Bermuda, Financial management, Fard, Management, Software as a service

FREDERICTON, NB, May 16, 2023 /PRNewswire/ -- Introhive, the world's leading Customer Intelligence Platform, is thrilled to announce the appointment of Saeideh Fard as its new Chief Financial Officer.

Key Points: 
  • FREDERICTON, NB, May 16, 2023 /PRNewswire/ -- Introhive, the world's leading Customer Intelligence Platform, is thrilled to announce the appointment of Saeideh Fard as its new Chief Financial Officer.
  • Fard, a seasoned executive with extensive background in SaaS, finance, and operations, brings a wealth of scaling expertise to the Introhive team.
  • Fard has a strong track record of driving growth, improving financial performance, and successfully executing mergers and acquisitions.
  • As CFO, she will play a critical role in shaping Introhive's financial strategy, optimizing resource allocation, and ensuring financial stability and scalability.

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET

Retrieved on: 
Monday, May 8, 2023
Health, Infectious Diseases, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, COVID-19, Calendar, Clinical trial, Respiratory syncytial virus, Sale, Medication, Patent, Patient, AbbVie, Glecaprevir/pibrentasvir, Viral, OMERS, HCV, Fiscal, Pharmaceutical industry, Cryptocurrency, Pfizer, SPRINT

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today reported financial results for its fiscal second quarter ended March 31, 2023.

Key Points: 
  • Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today reported financial results for its fiscal second quarter ended March 31, 2023.
  • “This vision is supported by positive topline data from our SPRINT Phase 2 study announced today.
  • The increase was due to increased stock-related compensation expense and legal fees associated with our patent infringement suit against Pfizer.
  • Enanta will host a conference call and webcast today at 4:30 p.m.